InterCure Statistics

Total Valuation

InterCure has a market cap or net worth of $71.50 million. The enterprise value is $110.96 million.

Market Cap	71.50M
Enterprise Value	110.96M

Important Dates

The next estimated earnings date is Friday, August 15, 2025, after market close.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

InterCure has 47.16 million shares outstanding. The number of shares has increased by 0.65% in one year.

Current Share Class	47.16M
Shares Outstanding	47.16M
Shares Change (YoY)	+0.65%
Shares Change (QoQ)	-7.94%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	27.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.09
Forward PS	0.18
PB Ratio	0.65
P/TBV Ratio	1.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.53.

Current Ratio	1.73
Quick Ratio	0.96
Debt / Equity	0.53
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-4.26

Financial Efficiency

Return on equity (ROE) is -17.03% and return on invested capital (ROIC) is -8.71%.

Return on Equity (ROE)	-17.03%
Return on Assets (ROA)	-7.09%
Return on Invested Capital (ROIC)	-8.71%
Return on Capital Employed (ROCE)	-16.40%
Revenue Per Employee	$204,923
Profits Per Employee	-$58,166
Employee Count	320
Asset Turnover	0.31
Inventory Turnover	1.74

Taxes

Income Tax	-3.99M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.86% in the last 52 weeks. The beta is 0.58, so InterCure's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-27.86%
50-Day Moving Average	1.52
200-Day Moving Average	1.58
Relative Strength Index (RSI)	44.04
Average Volume (20 Days)	15,089

Short Selling Information

The latest short interest is 14,229, so 0.03% of the outstanding shares have been sold short.

Short Interest	14,229
Short Previous Month	16,508
Short % of Shares Out	0.03%
Short % of Float	0.05%
Short Ratio (days to cover)	1.98

Income Statement

In the last 12 months, InterCure had revenue of $65.58 million and -$18.61 million in losses. Loss per share was -$0.41.

Revenue	65.58M
Gross Profit	11.55M
Operating Income	-24.13M
Pretax Income	-15.91M
Net Income	-18.61M
EBITDA	-21.48M
EBIT	-24.13M
Loss Per Share	-$0.41

Full Income Statement

Balance Sheet

The company has $21.59 million in cash and $58.04 million in debt, giving a net cash position of -$36.45 million or -$0.77 per share.

Cash & Cash Equivalents	21.59M
Total Debt	58.04M
Net Cash	-36.45M
Net Cash Per Share	-$0.77
Equity (Book Value)	109.18M
Book Value Per Share	2.31
Working Capital	45.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$18.37 million and capital expenditures -$1.20 million, giving a free cash flow of -$21.14 million.

Operating Cash Flow	-18.37M
Capital Expenditures	-1.20M
Free Cash Flow	-21.14M
FCF Per Share	-$0.45

Full Cash Flow Statement

Margins

Gross margin is 17.61%, with operating and profit margins of -36.80% and -28.38%.

Gross Margin	17.61%
Operating Margin	-36.80%
Pretax Margin	-36.56%
Profit Margin	-28.38%
EBITDA Margin	-32.75%
EBIT Margin	-36.80%
FCF Margin	n/a

Dividends & Yields

InterCure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.65%
Shareholder Yield	-0.65%
Earnings Yield	-26.03%
FCF Yield	-29.57%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

InterCure has an Altman Z-Score of 0.24 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.24
Piotroski F-Score	1